Experts explore the potential of medical cannabis in the treatment of Alzheimer's disease.
Several phytocannabinoids, terpenes and flavonoids demonstrated neuroprotective properties.
A new study suggests CBN has the potential for treating age-related neurodegenerative diseases.
Findings have been published from what is thought to be the first human trial of a THC-based drug in Alzheimer’s patients
The number of people living with Alzheimer's disease is expected to triple by 2050